LI Dongjing, MA Wei, XU Jiahui, et al. NOD1 promotes breast cancer progression through remodeling tumor-associated macrophage in tumor immune microenvironment[J]. China Oncology, 2026, 36(1): 47-56.
DOI:
LI Dongjing, MA Wei, XU Jiahui, et al. NOD1 promotes breast cancer progression through remodeling tumor-associated macrophage in tumor immune microenvironment[J]. China Oncology, 2026, 36(1): 47-56. DOI: 10.19401/j.cnki.1007-3639.2026.01.005.
NOD1 promotes breast cancer progression through remodeling tumor-associated macrophage in tumor immune microenvironment
2025 research hotspots and prospects of endocrine therapy for HR+/HER2- breast cancer
Progress and outlook of fundamental and translational breast cancer research in China, 2025
Precision medicine in breast cancer in 2025: advances and future directions
Progress and future directions of important clinical trial on breast cancer in China in 2025
A single-center retrospective study on the feasibility of omitting axillary surgery in patients with HR+/HER- early-stage breast cancer
Related Author
张蓝心
高子慧
李宁
韩佳鹏
赵作伟
李曼
CHE Xiangxian
XIE Yifan
Related Institution
大连医科大学附属第二医院乳腺肿瘤科
大连医科大学
大连大学
Department of Breast Surgery, Fudan University Shanghai Cancer Center/Fudan University Breast Cancer Institute, Department of Oncology, Shanghai Medical College, Fudan University
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College